Showing results (2411-2420 of 3,030) with videos related to
Sort By:
Pageof 303
Current Pharmaceutical Biotechnology|September 30, 2010
Protective effect of natural antioxidants on heart against ischemia-reperfusion damageYan Zhao, Baolu ZhaoCurrent Pharmaceutical Biotechnology|September 16, 2009
Evaluation of ISCOMs for immunization against hepatitis BR S Pandey, V K DixitCurrent Pharmaceutical Biotechnology|September 16, 2009
Comparative binding analysis of monoclonal antibodies against native and mutant type in ErbB2 receptor: a theoretical modeling approachR Rajasekaran, Sethumadhavan RaoCurrent Pharmaceutical Biotechnology|September 16, 2009
Chlorophytum borivilianum: a white gold for biopharmaceuticals and neutraceuticalsGulab Singh Thakur, Manoranjan Bag, Bhagwan S Sanodiya, et al.Current Pharmaceutical Biotechnology|April 28, 2010
RNAi screening for the discovery of novel modulators of human diseaseAttila A Seyhan, Terence E RyaCurrent Pharmaceutical Biotechnology|April 28, 2010
Clinical molecular imaging with PET agents other than 18F-FDGLance T Hall, Aaron F Struck, Scott B PerlmanCurrent Pharmaceutical Biotechnology|April 28, 2010
Myocardial expression of TNF-alpha, IL-1beta, IL-6, IL-8, IL-10 and MCP-1 after a single MDMA dose administered in a rat modelMargherita Neri, Stefania Bello, Alessandro Bonsignore, et al.Current Pharmaceutical Biotechnology|April 28, 2010
Mechanisms underlying the hepatotoxic effects of ecstasyMárcia Carvalho, Helena Pontes, Fernando Remião, et al.Current Pharmaceutical Biotechnology|April 28, 2010
Mechanisms of MDMA (ecstasy)-induced oxidative stress, mitochondrial dysfunction, and organ damageByoung-Joon Song, Kwan-Hoon Moon, Vijay V Upreti, et al.Current Pharmaceutical Biotechnology|April 28, 2010
Mice in ecstasy: advanced animal models in the study of MDMAChristophe P Stove, Els A De Letter, Michel H A Piette, et al.Pageof 303